Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ZYME compared with ANAB: revenue, margins and what each company keeps, and the suppliers and customers both name
ZYME
Zymeworks Inc.
Change
Mkt cap
Revenue
Revenue
ANAB
Anaptysbio, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ZYME
Zymeworks Inc.
vs
ANAB
Anaptysbio, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
ZYME
with
ANAB
Uncorrelated: r 0.23 · 499D.
Shared co-movers
2
with ZYME
with ANAB
NRIX
Nurix Therapeutics, Inc.
r 0.36
r 0.32
DNLI
Denali Therapeutics Inc.
r 0.37
r 0.28
ZYME, solid
ANAB, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
ZYME
Zymeworks Inc.
Change
30.13
· pre 30.14
· delayed
Mkt cap
$2.2B
Revenue
$5M
Q2 FY26
Revenue
$106M
FY25
ANAB
Anaptysbio, Inc
Change
47.75
· pre 47.75
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$1.4B
Revenue
$26M
Q1 FY26
Revenue
$235M
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
ZYME
Zymeworks Inc.
vs
ANAB
Anaptysbio, Inc
30.13
pre 30.14
delayed
Price
47.75
pre 47.75
delayed
$2.2B
Mkt cap
$1.4B
Q2 FY26
$5M
Revenue
$26M
Q1 FY26
FY25
$106M
Revenue
$235M
FY25
Change
Change
ZYME
30.13
vs
ANAB
47.75
Pre-market
Nov 3 '26
delayed